Please assess the completion status of the following clinical trial:

Trial Title: Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Personally signed and dated informed consent document.~* Randomized and treated with subcutaneous investigational product in a tanezumab study and has completed the study or been withdrawn from the study.~* Actual or planned total knee, hip or shoulder replacement surgery during the tanezumab study.~* Willing and able to comply with scheduled visits and other study procedures.~Exclusion Criteria:~- None.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cohort 1 (Type: OTHER): long-term observational study of subjects from tanezumab parent study

Based on this trial design, predict the completion outcome and termination type (if applicable).